Cost of Capital for Pharmaceutical, Biotechnology, and Medical Device Firms
Year of publication: |
2014
|
---|---|
Authors: | Harrington, Scott E. |
Publisher: |
[2014]: [S.l.] : SSRN |
Subject: | Kapitalkosten | Cost of capital | Biotechnologie | Biotechnology | Pharmaindustrie | Pharmaceutical industry | Biotechnologie-Industrie | Biotechnology industry | Medizinprodukt | Medical device | Arzneimittel | Pharmaceuticals | Pharmakologie | Pharmacology |
Extent: | 1 Online-Ressource (29 p) |
---|---|
Type of publication: | Book / Working Paper |
Language: | English |
Notes: | Nach Informationen von SSRN wurde die ursprüngliche Fassung des Dokuments November 13, 2009 erstellt |
Other identifiers: | 10.2139/ssrn.1512938 [DOI] |
Classification: | L6 - Industry Studies: Manufacturing ; G1 - General Financial Markets |
Source: | ECONIS - Online Catalogue of the ZBW |
-
Cost of Capital for Pharmaceutical, Biotechnology, and Medical Device Firms
Harrington, Scott E., (2012)
-
Kale, Dinar, (2019)
-
Financing biomedical innovation
Lo, Andrew W., (2022)
- More ...
-
Harrington, Scott E., (2008)
-
All events induce variance : analyzing abnormal returns when effects vary across firms
Harrington, Scott E., (2007)
-
The financial crisis, systemic risk, and the future of insurance regulation
Harrington, Scott E., (2009)
- More ...